PHR logo

Phreesia (PHR) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

18 July 2019

Indexes:

Not included

Description:

Phreesia is a healthcare technology company that provides patient intake solutions. Their platform helps medical practices streamline patient registration, appointment scheduling, and billing processes. By improving communication and efficiency, Phreesia enhances the patient experience and supports healthcare providers in managing their operations effectively.

Key Details

Price

$20.30

Annual Revenue

$356.30 M(+26.84% YoY)

Annual EPS

-$2.51(+25.30% YoY)

Annual ROE

-50.77%

Beta

1.87

Events Calendar

Earnings

Next earnings date:

Dec 09, 2024

Recent quarterly earnings:

Sept 04, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

27 Sept '24 RBC Capital
Sector Perform
09 Sept '24 JP Morgan
Overweight
06 Sept '24 Truist Securities
Buy
06 Sept '24 Baird
Outperform
05 Sept '24 RBC Capital
Sector Perform
05 Sept '24 Needham
Buy
05 Sept '24 JMP Securities
Market Outperform
05 Sept '24 DA Davidson
Buy
05 Sept '24 Canaccord Genuity
Buy
30 Aug '24 JMP Securities
Market Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last?
Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last?
Phreesia (PHR) Moves 13.9% Higher: Will This Strength Last?
PHR
zacks.com07 November 2024

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
PHR
businesswire.com01 November 2024

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it will release its fiscal third quarter 2025 financial results after the close of market trading on Monday, Dec. 9, 2024.

Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
PHR
businesswire.com28 October 2024

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announced that it has achieved Oracle Validated Integration with Oracle Health EHR Expertise for its integration of the Phreesia platform.

Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround
Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround
Down -10.25% in 4 Weeks, Here's Why Phreesia (PHR) Looks Ripe for a Turnaround
PHR
zacks.com10 October 2024

Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript
Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript
Phreesia, Inc. (PHR) Q2 2025 Earnings Call Transcript
PHR
seekingalpha.com04 September 2024

Phreesia, Inc. (NYSE:PHR ) Q2 2025 Earnings Conference Call September 4, 2024 5:00 PM ET Company Participants Balaji Gandhi - Chief Financial Officer Chaim Indig - Chief Executive Officer Conference Call Participants Anne Samuel - JPMorgan Ryan Daniels - William Blair Scott Schoenhaus - KeyBanc Jessica Tassan - Piper Sandler Jailendra Singh - Truist Securities Glen Santangelo - Jefferies Stephanie Davis - Barclays Joe Vruwink - Baird John Ransom - Raymond James Richard Close - Canaccord Security Daniel Grosslight - Citi Sean Dodge - RBC Capital Markets Jeff Garro - Stephens Matthew Shea - Needham & Company Jack Wallace - Guggenheim Aaron Kimson - Citizens JMP Operator Good evening, ladies and gentlemen, and welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a listen-only mode.

Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Phreesia (PHR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
PHR
zacks.com04 September 2024

The headline numbers for Phreesia (PHR) give insight into how the company performed in the quarter ended July 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates
Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates
Phreesia (PHR) Reports Q2 Loss, Tops Revenue Estimates
PHR
zacks.com04 September 2024

Phreesia (PHR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.68 per share a year ago.

Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Phreesia (PHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
PHR
zacks.com29 August 2024

Get a deeper insight into the potential performance of Phreesia (PHR) for the quarter ended July 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Phreesia, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Phreesia (PHR)
Phreesia, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Phreesia (PHR)
Phreesia, Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Phreesia (PHR)
PHR
accesswire.com26 August 2024

NEW YORK, NY / ACCESSWIRE / August 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

Shareholders that Lost Money on Phreesia, Inc.(PHR) Should Contact Levi & Korsinsky About Securities Fraud Investigation - PHR
Shareholders that Lost Money on Phreesia, Inc.(PHR) Should Contact Levi & Korsinsky About Securities Fraud Investigation - PHR
Shareholders that Lost Money on Phreesia, Inc.(PHR) Should Contact Levi & Korsinsky About Securities Fraud Investigation - PHR
PHR
accesswire.com23 August 2024

NEW YORK, NY / ACCESSWIRE / August 23, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Phreesia, Inc. ("Phreesia") (NYSE:PHR) concerning possible violations of federal securities laws. Phreesia issued a press release on May 30, 2024, announcing financial results for the first quarter of its fiscal year 2025.

FAQ

  • What is the primary business of Phreesia?
  • What is the ticker symbol for Phreesia?
  • Does Phreesia pay dividends?
  • What sector is Phreesia in?
  • What industry is Phreesia in?
  • What country is Phreesia based in?
  • When did Phreesia go public?
  • Is Phreesia in the S&P 500?
  • Is Phreesia in the NASDAQ 100?
  • Is Phreesia in the Dow Jones?
  • When was Phreesia's last earnings report?
  • When does Phreesia report earnings?
  • Should I buy Phreesia stock now?

What is the primary business of Phreesia?

Phreesia is a healthcare technology company that provides patient intake solutions. Their platform helps medical practices streamline patient registration, appointment scheduling, and billing processes. By improving communication and efficiency, Phreesia enhances the patient experience and supports healthcare providers in managing their operations effectively.

What is the ticker symbol for Phreesia?

The ticker symbol for Phreesia is NYSE:PHR

Does Phreesia pay dividends?

No, Phreesia does not pay dividends

What sector is Phreesia in?

Phreesia is in the Healthcare sector

What industry is Phreesia in?

Phreesia is in the Health Information Services industry

What country is Phreesia based in?

Phreesia is headquartered in United States

When did Phreesia go public?

Phreesia's initial public offering (IPO) was on 18 July 2019

Is Phreesia in the S&P 500?

No, Phreesia is not included in the S&P 500 index

Is Phreesia in the NASDAQ 100?

No, Phreesia is not included in the NASDAQ 100 index

Is Phreesia in the Dow Jones?

No, Phreesia is not included in the Dow Jones index

When was Phreesia's last earnings report?

Phreesia's most recent earnings report was on 4 September 2024

When does Phreesia report earnings?

The next expected earnings date for Phreesia is 9 December 2024

Should I buy Phreesia stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions